DMD and Duchenne muscular dystrophy: Given the established utility of EIM in monitoring disease progression in patients with DMD, taken together with our results, we conclude that EIM reactance has the potential to serve as a valuable and translatable biomarker for monitoring the restoration of dystrophin-deficient muscle abnormalities by exon skippers in clinical studies of DMD.